Last reviewed · How we verify
NCT05792267
Clinical Research on a Novel Deep-learning Based System in Pancreatic Endoscopic Ultrasound Scanning
NA trial testing artificial intelligence system in Pancreatic Disease in 200 participants. Currently enrolling.
30 June 2024
Quick facts
| Lead sponsor | The Third Xiangya Hospital of Central South University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 200 |
| Start date | 1 January 2021 |
| Primary completion | 30 June 2024 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- artificial intelligence system
Conditions studied
- Pancreatic Disease — all drugs for Pancreatic Disease →
Sponsor
The Third Xiangya Hospital of Central South University
Who can join
Adults 18 to 80, any sex, with Pancreatic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to develop and verify the auxiliary role of the artificial intelligence system in pancreatic ultrasound endoscopic scanning.The main questions it aims to answer are as follows: 1.The comparison of the image recognition accuracy between the artificial intelligence system and the ultrasound endoscopist; 2. Whether the artificial intelligence system can improve the efficiency of the pancreatic scanning for the ultrasound endoscopist. Participants will undergo pancreatic EUS with or without the assistance of the artificial intelligence system.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05792267
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of artificial intelligence system
Trials testing the same drug.
- NCT06335654 — Real-time Artificial Intelligence-based Endocytoscopic Diagnosis of Colorectal Neoplasms · completed
Other recruiting trials for Pancreatic Disease
Currently open trials in the same condition.
- NCT06824909 — Endoscopic Ultrasound-guided Fine-needle Aspiration of Solid Pancreatic Lesions With Rapid Staining of Cytological Smear · recruiting
- NCT06764134 — Assessing Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON Endostapler · recruiting
- NCT06552078 — Activation of Biobank Registry for Bilio-pancreatic Diseases · recruiting
- NCT04949282 — Spanish Series of Patients Treated With the Radionuclide Lutetium177 · recruiting
- NCT05193162 — Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases · recruiting
Other The Third Xiangya Hospital of Central South University trials
Trials by the same sponsor.
- NCT07353307 — A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia Afte · Phase 3 · recruiting
- NCT07123207 — Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Dis · NA · recruiting
- NCT07034664 — IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study · recruiting
- NCT07093294 — Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter · recruiting
- NCT07039097 — A Multicenter, Prospective, Randomized, Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resectio · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05792267 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Third Xiangya Hospital of Central South University
- Last refreshed: 12 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05792267.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing